Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHMDW
6101
SCHMID Group N.V. Warrants
SHMDW
| $108K | ﹤0.01% |
67,934
-7,305
| -10% | -$17.6K |
|
|
NKLR
6102
Terra Innovatum Global N.V.
NKLR
$571M
| $108K | ﹤0.01% |
+23,242
| New | +$114K |
|
6103
Tenaya Therapeutics
TNYA
$167M
| $107K | ﹤0.01% |
154,801
+86,824
| +128% | +$64.1K |
|
|
SLSR
6104
Solaris Resources
SLSR
$1.3B
| $105K | ﹤0.01% |
12,295
-639,212
| -98% | -$5.9M |
|
6105
Research Solutions
RSSS
$73.6M
| $105K | ﹤0.01% |
46,627
+3,648
| +8% | +$9.33K |
|
|
AGEN
6106
Agenus
AGEN
$255M
| $105K | ﹤0.01% |
31,454
-30,295
| -49% | -$101K |
|
|
SBC
6107
SBC Medical Group
SBC
$327M
| $105K | ﹤0.01% |
25,087
+13,764
| +122% | +$57.4K |
|
|
OXLC
6108
Oxford Lane Capital
OXLC
$824M
| $105K | ﹤0.01% |
+10,707
| New | +$118K |
|
|
CAN
6109
Canaan Creative
CAN
$192M
| $105K | ﹤0.01% |
242,209
-39,586
| -14% | -$23.1K |
|
6110
Braskem
BAK
$972M
| $104K | ﹤0.01% |
28,409
-62,483
| -69% | -$237K |
|
6111
CALL
Bakkt Inc
BKKT
$338M
| $103K | ﹤0.01% |
14,000
| – | – |
|
6112
LivePerson
LPSN
$20.8M
| $103K | ﹤0.01% |
40,406
-20,861
| -34% | -$63.5K |
|
|
PLYX
6113
Polaryx Therapeutics Inc
PLYX
$97.7M
| $102K | ﹤0.01% |
+13,483
| New | +$87.1K |
|
6114
Leslie's
LESL
$10.8M
| $101K | ﹤0.01% |
90,257
-12,171
| -12% | -$15.6K |
|
6115
Soluna Holdings
SLNH
$194M
| $99K | ﹤0.01% |
140,073
+123,233
| +732% | +$131K |
|
|
ANNA
6116
AleAnna Inc
ANNA
$125M
| $98.9K | ﹤0.01% |
+11,929
| New | +$42K |
|
6117
Purple Innovation
PRPL
$35.8M
| $96.7K | ﹤0.01% |
5,851
+974
| +20% | +$17K |
|
|
DEFT
6118
Defi Technologies
DEFT
$166M
| $95.7K | ﹤0.01% |
173,233
-36,897
| -18% | -$28.2K |
|
6119
Vince Holding Corp
VNCE
$77.7M
| $95.4K | ﹤0.01% |
39,599
+2,701
| +7% | +$7.42K |
|
|
WSHP
6120
WeShop Holdings
WSHP
$60M
| $95.3K | ﹤0.01% |
+12,776
| New | +$512K |
|
6121
Enlivex Ltd
ENLV
$71.7M
| $95K | ﹤0.01% |
+6,806
| New | +$108K |
|
6122
Falcon's Beyond Global Warrants
FBYDW
$16M
| $94.5K | ﹤0.01% |
50,000
| – | – |
|
6123
Townsquare Media
TSQ
$106M
| $93.6K | ﹤0.01% |
17,242
-30,910
| -64% | -$195K |
|
6124
Cheche Group
CCG
$30.3M
| $93.3K | ﹤0.01% |
3,016
+1,174
| +64% | +$33K |
|
|
SGMO
6125
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $93.2K | ﹤0.01% |
377,287
+186,642
| +98% | +$74.3K |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.